Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

34 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Long-term cardiac surveillance and outcomes of COVID-19 patients.
Mitrani RD, Dabas N, Alfadhli J, Lowery MH, Best TM, Hare JM, Myerburg RJ, Goldberger JJ. Mitrani RD, et al. Among authors: lowery mh. Trends Cardiovasc Med. 2022 Nov;32(8):465-475. doi: 10.1016/j.tcm.2022.06.003. Epub 2022 Jun 16. Trends Cardiovasc Med. 2022. PMID: 35718289 Free PMC article. Review.
Utility of exercise testing to assess athletes for post COVID-19 myocarditis.
Mitrani RD, Alfadhli J, Lowery MH, Best TM, Hare JM, Fishman J, Dong C, Siegel Y, Scavo V, Basham GJ, Myerburg RJ, Goldberger JJ. Mitrani RD, et al. Among authors: lowery mh. Am Heart J Plus. 2022 Feb;14:100125. doi: 10.1016/j.ahjo.2022.100125. Epub 2022 Mar 31. Am Heart J Plus. 2022. PMID: 35378797 Free PMC article.
SARS-CoV-2 Cardiac Involvement in Young Competitive Athletes.
Moulson N, Petek BJ, Drezner JA, Harmon KG, Kliethermes SA, Patel MR, Baggish AL; Outcomes Registry for Cardiac Conditions in Athletes Investigators. Moulson N, et al. Circulation. 2021 Jul 27;144(4):256-266. doi: 10.1161/CIRCULATIONAHA.121.054824. Epub 2021 Apr 17. Circulation. 2021. PMID: 33866822 Free PMC article.
Prevalence and clinical implications of persistent or exertional cardiopulmonary symptoms following SARS-CoV-2 infection in 3597 collegiate athletes: a study from the Outcomes Registry for Cardiac Conditions in Athletes (ORCCA).
Petek BJ, Moulson N, Baggish AL, Kliethermes SA, Patel MR, Churchill TW, Harmon KG, Drezner JA; ORCCA Investigators. Petek BJ, et al. Br J Sports Med. 2022 Aug;56(16):913-918. doi: 10.1136/bjsports-2021-104644. Epub 2021 Nov 1. Br J Sports Med. 2022. PMID: 34725052 Free PMC article.
Cardiovascular Outcomes in Collegiate Athletes After SARS-CoV-2 Infection: 1-Year Follow-Up From the Outcomes Registry for Cardiac Conditions in Athletes.
Petek BJ, Moulson N, Drezner JA, Harmon KG, Kliethermes SA, Churchill TW, Patel MR, Baggish AL; ORCCA Investigators. Petek BJ, et al. Circulation. 2022 May 31;145(22):1690-1692. doi: 10.1161/CIRCULATIONAHA.121.058272. Epub 2022 May 12. Circulation. 2022. PMID: 35545946 Free article. No abstract available.
Dose Comparison Study of Allogeneic Mesenchymal Stem Cells in Patients With Ischemic Cardiomyopathy (The TRIDENT Study).
Florea V, Rieger AC, DiFede DL, El-Khorazaty J, Natsumeda M, Banerjee MN, Tompkins BA, Khan A, Schulman IH, Landin AM, Mushtaq M, Golpanian S, Lowery MH, Byrnes JJ, Hendel RC, Cohen MG, Valasaki K, Pujol MV, Ghersin E, Miki R, Delgado C, Abuzeid F, Vidro-Casiano M, Saltzman RG, DaFonseca D, Caceres LV, Ramdas KN, Mendizabal A, Heldman AW, Mitrani RD, Hare JM. Florea V, et al. Among authors: lowery mh. Circ Res. 2017 Nov 10;121(11):1279-1290. doi: 10.1161/CIRCRESAHA.117.311827. Epub 2017 Sep 18. Circ Res. 2017. PMID: 28923793 Free PMC article. Clinical Trial.
Randomized Comparison of Allogeneic Versus Autologous Mesenchymal Stem Cells for Nonischemic Dilated Cardiomyopathy: POSEIDON-DCM Trial.
Hare JM, DiFede DL, Rieger AC, Florea V, Landin AM, El-Khorazaty J, Khan A, Mushtaq M, Lowery MH, Byrnes JJ, Hendel RC, Cohen MG, Alfonso CE, Valasaki K, Pujol MV, Golpanian S, Ghersin E, Fishman JE, Pattany P, Gomes SA, Delgado C, Miki R, Abuzeid F, Vidro-Casiano M, Premer C, Medina A, Porras V, Hatzistergos KE, Anderson E, Mendizabal A, Mitrani R, Heldman AW. Hare JM, et al. Among authors: lowery mh. J Am Coll Cardiol. 2017 Feb 7;69(5):526-537. doi: 10.1016/j.jacc.2016.11.009. Epub 2016 Nov 14. J Am Coll Cardiol. 2017. PMID: 27856208 Free PMC article. Clinical Trial.
Transendocardial mesenchymal stem cells and mononuclear bone marrow cells for ischemic cardiomyopathy: the TAC-HFT randomized trial.
Heldman AW, DiFede DL, Fishman JE, Zambrano JP, Trachtenberg BH, Karantalis V, Mushtaq M, Williams AR, Suncion VY, McNiece IK, Ghersin E, Soto V, Lopera G, Miki R, Willens H, Hendel R, Mitrani R, Pattany P, Feigenbaum G, Oskouei B, Byrnes J, Lowery MH, Sierra J, Pujol MV, Delgado C, Gonzalez PJ, Rodriguez JE, Bagno LL, Rouy D, Altman P, Foo CW, da Silva J, Anderson E, Schwarz R, Mendizabal A, Hare JM. Heldman AW, et al. Among authors: lowery mh. JAMA. 2014 Jan 1;311(1):62-73. doi: 10.1001/jama.2013.282909. JAMA. 2014. PMID: 24247587 Free PMC article. Clinical Trial.
Rationale and design of the allogeneiC human mesenchymal stem cells (hMSC) in patients with aging fRAilTy via intravenoUS delivery (CRATUS) study: A phase I/II, randomized, blinded and placebo controlled trial to evaluate the safety and potential efficacy of allogeneic human mesenchymal stem cell infusion in patients with aging frailty.
Golpanian S, DiFede DL, Pujol MV, Lowery MH, Levis-Dusseau S, Goldstein BJ, Schulman IH, Longsomboon B, Wolf A, Khan A, Heldman AW, Goldschmidt-Clermont PJ, Hare JM. Golpanian S, et al. Among authors: lowery mh. Oncotarget. 2016 Mar 15;7(11):11899-912. doi: 10.18632/oncotarget.7727. Oncotarget. 2016. PMID: 26933813 Free PMC article. Clinical Trial.
34 results